These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 669872)

  • 1. The distribution of sulfamerazin between plasma, cerebrospinal fluid, and bile in humans.
    Terhaag B; Scherber A; Schaps P; Winkler H
    Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):274-6. PubMed ID: 669872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distribution of lithium into cerebrospinal fluid, brain tissue and bile in man.
    Terhaag B; Scherber A; Schaps P; Winkler H
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):333-5. PubMed ID: 669880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration behavior of carbamazepine in bile and plasma of man.
    Terhaag B; Richter K; Diettrich H
    Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):607-9. PubMed ID: 730428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biliary elimination of sulfamerazin in rat and man--a comparison.
    Gramatté T; Terhaag B; Fischer E; Varga F
    Arch Toxicol Suppl; 1985; 8():348-50. PubMed ID: 3868363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biliary elimination of the selective beta-receptor blocking drug talinolol in man.
    Terhaag B; Gramatté T; Richter K; Voss J; Feller K
    Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):170-2. PubMed ID: 2565889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The kinetics of sulfamerazine (Mebacid) and the effect of sulfamerazine therapy on p-aminohippuric acid clearance in pregnancy].
    Peiker G; Traeger A; Nöschel H
    Zentralbl Gynakol; 1976; 98(16):970-5. PubMed ID: 973491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of sulfaclomide and sulfamerazine in patients with impaired renal function after first and after repeated application.
    Traeger A; Stein G
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):315-20. PubMed ID: 892948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations.
    Day RO; Francis H; Vial J; Geisslinger G; Williams KM
    J Rheumatol; 1995 Dec; 22(12):2295-303. PubMed ID: 8835565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of sulfamerazine and antipyrine in neonatal and young lambs.
    De Backer P; Belpaire FM; Bogaert MG; Debackere M
    Am J Vet Res; 1982 Oct; 43(10):1744-51. PubMed ID: 7149373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of mitomycin C in humans.
    den Hartigh J; McVie JG; van Oort WJ; Pinedo HM
    Cancer Res; 1983 Oct; 43(10):5017-21. PubMed ID: 6411336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid and blood concentrations of toltrazuril 5% suspension in the horse after oral dosing.
    Furr M; Kennedy T
    Vet Ther; 2000; 1(2):125-32. PubMed ID: 19757559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic study of a cephalosporin: cefoperazone in patients with a Kehr drain].
    Farquet C; Marti MC; Balant L; Cochet B; Rudhardt M; Fabre J; Rohner A
    Schweiz Med Wochenschr; 1982 Jan; 112(4):123-9. PubMed ID: 6461067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of radiolabelled quinlukast in rats.
    Syrovatko M; Laznickova A; Laznicek M
    J Pharm Biomed Anal; 2005 Jun; 38(2):313-9. PubMed ID: 15925224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A
    Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics, urinary and biliary excretion of pipecuronium bromide.
    Wierda JM; Szenohradszky J; De Wit AP; Zentai G; Agoston S; Kakas M; Kleef UW; Meijer DK
    Eur J Anaesthesiol; 1991 Nov; 8(6):451-7. PubMed ID: 1662599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of pharmacokinetics of the combination trimethoprim and sulfamethoxazole in patients with liver diseases and healthy persons].
    Rieder VJ; Schwartz DE
    Arzneimittelforschung; 1975 Apr; 25(4):656-66. PubMed ID: 1174084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of azosemide in patients with T-drain after cholecystectomy.
    Schuchmann HW; Rösch W; Koch U; Maurer HH; Stengl U; Mutschler E
    Arzneimittelforschung; 1992 Jun; 42(6):812-4. PubMed ID: 1418035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.